Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Sh Pharmaceuticals Limited, is an unlisted public company incorporated on 29 September, 1995. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 5.00 cr and the total paid-up capital is INR 1.27 cr.
The current status of Sh Pharmaceuticals Limited is - Active.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 1.5 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sanjay Chillakuru Reddy | 01247277 | 20 years |
| Director | Sudhakar Malisetti | 01247290 | 20 years |
| Director | Bala Lanka Bhaskar | 03593103 | 16 years |
| Director | Aditya Tikkavarapu Reddy | 07213229 | 4 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| GIRIJA INVESTMENTS PVT LTD |
Active
|
53.0 L | 1 | Telangana |
| KAMIREDDY INVESTMENTS PVT LTD |
Strike Off
|
49.6 L | 1 | Telangana |
| GREEN EARTH AGRI FOODS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
| SYNGEN BIO FUELS PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Telangana |
| COLLECTIVE FITNESS PRIVATE LIMITED |
Active
|
50.0 L | 2 | Telangana |
| INTEGRUM WATERTECH PRIVATE LIMITED |
Active
|
11.0 L | 1 | Telangana |
| SYNGEN AGRI PRODUCTS PRIVATE LIMITED |
Under Process of Striking Off
|
62.9 L | 1 | Telangana |
| UVB LIFE SCIENCES PRIVATE LIMITED |
Active
|
5.0 L | 2 | Telangana |
| ANIKSAN HEALTHCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| INTEGRUM REALTORS LLP |
Active
|
1.0 L | 3 | Telangana |
| DEEPADITYA DEVELOPERS INDIA LLP |
Active
|
1.0 L | 2 | Telangana |
| JIVANTA LIFE SCIENCES LLP |
Active
|
1.0 L | 1 | Telangana |
| EPSI BUILDING MANAGEMENT SERVICES LLP |
Active
|
1.0 L | 2 | Telangana |
| DOMUS DEVELOPERS INDIA LLP |
Active
|
1.0 L | 2 | Telangana |
| MONDO FOODS LLP |
Active
|
1.0 L | 2 | Telangana |
| WILD FOODS HOSPITALITY INDIA LLP |
Active
|
1.0 L | 2 | Telangana |
| EXPONENT CAPITAL LLP |
Active
|
1.0 L | 1 | Telangana |
| EREDITA FOODS LLP |
Active
|
1.0 L | 1 | Telangana |
| JIVANTA LABORATORIES PRIVATE LIMITED |
Active
|
52.3 L | 1 | Telangana |
| DEEPADITYA DEVELOPERS LIMITED |
Active
|
5.0 L | 1 | Telangana |
| DEEPADITYA CHITS PRIVATE LIMITED |
Active
|
5.7 L | 1 | Telangana |
| CYBERPORT INFRA PRIVATE LIMITED |
Active
|
50.0 L | 1 | Telangana |
| YATHVA INFRA PROJECTS LLP |
Active
|
1.0 L | 1 | Telangana |
| ALAIA DASPALLA HOSPITALITY LLP |
Active
|
1.0 L | 1 | ng |
The incorporation date of SH PHARMACEUTICALS LIMITED is 29 September, 1995
The authorized share capital of SH PHARMACEUTICALS LIMITED is INR ₹ 5.0 Cr.
The paid-up capital of SH PHARMACEUTICALS LIMITED is INR ₹ 1.3 Cr.
The registered address of SH PHARMACEUTICALS LIMITED is 6-3-348, "MID TOWN" 6TH FLOOR, "B " BLOCK, ROAD NO.1, BANJARA HILLS HYDERABAD Telangana - 500034
The CIN number of SH PHARMACEUTICALS LIMITED is U24230TG1995PLC021887.
Expand
Delete
Collapse
See
details
